Authors

• Matthias Miederer (ORCID: https://orcid.org/0000-0001-5075-5995)
• Robert Winzer (ORCID: https://orcid.org/0000-0002-6650-3992)
• Sebastian Böttcher (ORCID: https://orcid.org/0000-0002-3603-761X)
• Christoph Röllig (ORCID: https://orcid.org/0000-0002-3791-0548)
• Ingmar Glauche (ORCID: https://orcid.org/0000-0002-2524-1199)
• Raphael Teipel (ORCID: https://orcid.org/0000-0002-9985-6583)
• Andrea Gottschalk (ORCID: https://orcid.org/0000-0003-0378-9601)
• Rudi Apolle (ORCID: https://orcid.org/0000-0002-1375-0498)
• Heike Weidner (ORCID: https://orcid.org/0009-0001-6045-3349)
• Katharina Epp (ORCID: https://orcid.org/0009-0003-4882-552X)
• Malte von Bonin
• Karolin Trautmann-Grill
• Ivan Platzek
• Claudia Brogsitter
• Martin Bornhäuser
• Luisa Kleditsch

Institutions

• Heidelberg University (DE)
• Helmholtz-Zentrum Dresden-Rossendorf (DE)
• University Hospital Heidelberg (DE)
• National Center for Tumor Diseases (DE)
• University Hospital Carl Gustav Carus (DE)
• University of Rostock (DE)

Publication Details

Journal

Haematologica

Published

2026-05-21

DOI

https://doi.org/10.3324/haematol.2026.300672

Primary Topic

CAR-T cell therapy research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Pfizer
• Sanofi
• Gilead Sciences
• Technische Universität Dresden
• Swedish Orphan Biovitrum
• Grifols